Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome
- PMID: 30113663
- DOI: 10.1210/jc.2018-00935
Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome
Abstract
Context: Insulin resistance in skeletal muscle is a major risk factor for the development of type 2 diabetes in women with polycystic ovary syndrome (PCOS). Despite this, the mechanisms underlying insulin resistance in PCOS are largely unknown.
Objective: To investigate the genome-wide DNA methylation and gene expression patterns in skeletal muscle from women with PCOS and controls and relate them to phenotypic variations.
Design/participants: In a case-control study, skeletal muscle biopsies from women with PCOS (n = 17) and age-, weight-, and body mass index‒matched controls (n = 14) were analyzed by array-based DNA methylation and mRNA expression profiling.
Results: Eighty-five unique transcripts were differentially expressed in muscle from women with PCOS vs controls, including DYRK1A, SYNPO2, SCP2, and NAMPT. Furthermore, women with PCOS had reduced expression of genes involved in immune system pathways. Two CpG sites showed differential DNA methylation after correction for multiple testing. However, an mRNA expression of ∼30% of the differentially expressed genes correlated with DNA methylation levels of CpG sites in or near the gene. Functional follow-up studies demonstrated that KLF10 is under transcriptional control of insulin, where insulin promotes glycogen accumulation in myotubes of human muscle cells. Testosterone downregulates the expression levels of COL1A1 and MAP2K6.
Conclusion: PCOS is associated with aberrant skeletal muscle gene expression with dysregulated pathways. Furthermore, we identified specific changes in muscle DNA methylation that may affect gene expression. This study showed that women with PCOS have epigenetic and transcriptional changes in skeletal muscle that, in part, can explain the metabolic abnormalities seen in these women.
Trial registration: ClinicalTrials.gov NCT01457209.
Comment in
-
Mechanisms of insulin resistance.Nat Rev Endocrinol. 2018 Oct;14(10):565. doi: 10.1038/s41574-018-0083-4. Nat Rev Endocrinol. 2018. PMID: 30108279 No abstract available.
Similar articles
-
DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.Reprod Toxicol. 2022 Aug;111:11-19. doi: 10.1016/j.reprotox.2022.04.010. Epub 2022 May 10. Reprod Toxicol. 2022. PMID: 35562068 Review.
-
Electroacupuncture Mimics Exercise-Induced Changes in Skeletal Muscle Gene Expression in Women With Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2020 Jun 1;105(6):2027-41. doi: 10.1210/clinem/dgaa165. J Clin Endocrinol Metab. 2020. PMID: 32232327 Free PMC article.
-
Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.Oncotarget. 2016 May 10;7(19):27899-909. doi: 10.18632/oncotarget.8544. Oncotarget. 2016. PMID: 27056885 Free PMC article.
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
-
Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.J Clin Endocrinol Metab. 2008 Sep;93(9):3618-26. doi: 10.1210/jc.2008-0760. Epub 2008 Jun 10. J Clin Endocrinol Metab. 2008. PMID: 18544618 Clinical Trial.
Cited by
-
Polycystic ovary syndrome.Nat Rev Dis Primers. 2024 Apr 18;10(1):27. doi: 10.1038/s41572-024-00511-3. Nat Rev Dis Primers. 2024. PMID: 38637590 Review.
-
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease.Curr Cardiol Rep. 2024 Jun;26(6):483-495. doi: 10.1007/s11886-024-02050-5. Epub 2024 Apr 3. Curr Cardiol Rep. 2024. PMID: 38568339 Review.
-
Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS.Elife. 2024 Jan 5;12:RP87592. doi: 10.7554/eLife.87592. Elife. 2024. PMID: 38180081 Free PMC article.
-
Administration of adipose-derived mesenchymal stem cell conditioned medium improves ovarian function in polycystic ovary syndrome rats: involvement of epigenetic modifiers system.J Ovarian Res. 2023 Dec 15;16(1):238. doi: 10.1186/s13048-023-01317-9. J Ovarian Res. 2023. PMID: 38102694 Free PMC article.
-
An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome.J Clin Med. 2023 Sep 22;12(19):6120. doi: 10.3390/jcm12196120. J Clin Med. 2023. PMID: 37834765 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous